title: Successful solid organ transplantation from septicemic cadaveric donors: case report.
abstract: Systemic donor infections especially with gram-negative organisms are regarded as an absolute contraindication to cadaveric organ donation for transplantation. This is largely due to fear of transmitting the pathogenic organisms to the immunosuppressed recipient. However, due to the current shortage of organs available for transplantation, clinicians are faced with the option to use organs from infected donors. Between 1996 to January 2006, we collected 44 solid organs. Two out of nine donors had microorganisms from blood cultured. Case 1 was of 23-year old woman whose cause of brain death was intracerebral bleeding due to a traffic accident. The donor had stayed 9 days in the intensive care unit prior to brain death. Two kidneys, two livers (split), and or heart were used. Klebsiella was the organism on blood culture. Case 2 was of 35-year-old man; cause of brain death was cerebral hematoma due to traffic accident. The donor had stayed 6 days prior to brain death onset. The liver and two kidneys were used. Acinetobacter baumannii was yielded upon blood culture. All donors were treated with appropriate antibiotics for at least 48 hours prior to organ procurement with consequent negative blood cultures, while the recipients received the same culture-specific antibiotics for 10 days following transplantation. One donor (case 1) heart and both donor corneas were not used due to infection. All patients are alive with excellent graft function at a median of 90 days following transplantation. In conclusion, our results suggested that bacteremic donors with severe sepsis under proper treatment can be considered for transplantation.
authors.affiliation: Department of General Surgery, Gazi University Medical Faculty, Ankara, Turkey. mhakansozen@gmail.com
authors.forename: H
authors.initials: H
authors.lastname: Sözen
authors.forename: K
authors.initials: K
authors.lastname: Fidan
authors.forename: A
authors.initials: A
authors.lastname: Mahli
authors.forename: E
authors.initials: E
authors.lastname: Singin
authors.forename: N
authors.initials: N
authors.lastname: Buyan
authors.forename: S
authors.initials: S
authors.lastname: Sindel
authors.forename: O
authors.initials: O
authors.lastname: Söylemezoğlu
authors.forename: T
authors.initials: T
authors.lastname: Arinsoy
authors.forename: A
authors.initials: A
authors.lastname: Dalgic
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002102:Cadaver; D005260:Female; D006801:Humans; D016030:Kidney Transplantation / Q000502:physiology; D016031:Liver Transplantation / Q000502:physiology; D008297:Male; D018579:Patient Selection; D018805:Sepsis / Q000188:drug therapy; D014019:Tissue Donors; D020858:Tissue and Organ Harvesting
chemical_list: D000900:Anti-Bacterial Agents